Mari Olsen

Research Associate

Pancreatic cancer is the fourth leading cause of cancer-related deaths in the US. The 5-year survival rate is less than 5%. Most of these cancers are adenocarcinomas which are thought to be derived from the pancreatic ducts. Early diagnosis is difficult because of the relative lack of symptoms until the disease is far advanced and it can only be sampled using invasive procedures. There is an urgent need for markers which can be used for early diagnosis. Our goal is to identify genes useful in understanding the disease pathogenesis and identify genes which may be used as markers. To achieve this, we are using cDNA microarrays to study the gene expression profile of pancreatic adenocarcinomas.

Contact info